SPOTLIGHT: Debate blows up over comparative effectiveness research

With $1.1 billion allocated to comparative effectiveness research in the new stimulus package, the concept has suddenly gone from a wonkish concern to a topic of conversation among health advocates everywhere. The question, observers say, is whether a given interest group will be able to frame the research program to suit their agenda. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.